Moreover, NGF treatment of choroidal endothelial cells increases their migration by 50%, indicating that neurotrophins have the capacity to modulate neoangiogenic processes as seen in DR or AMD [201,207]. The gene discussed is BDNF; the disease is age-related macular degeneration.